UA35854A - Method for treating latent silicotuberculosis - Google Patents

Method for treating latent silicotuberculosis

Info

Publication number
UA35854A
UA35854A UA99010185A UA99010185A UA35854A UA 35854 A UA35854 A UA 35854A UA 99010185 A UA99010185 A UA 99010185A UA 99010185 A UA99010185 A UA 99010185A UA 35854 A UA35854 A UA 35854A
Authority
UA
Ukraine
Prior art keywords
silicotuberculosis
treating latent
latent
treating
day
Prior art date
Application number
UA99010185A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Ольга Миколаївна Сидоренко
Ольга Николаевна Сидоренко
Микола Зиновійович Слінченко
Николай Зиновьевич Слинченко
Лідія Лаврентіївна Філіпченко
Лидия Лаврентьевна Филипченко
Любов Іванівна Петрух
Любовь Ивановна Петрух
Олександр Павлович Кривонос
Александр Павлович Кривонос
Original Assignee
Український Науково-Дослідний Інститут Промислової Медицини
Украинский Научно-Исследовательский Институт Промышленной Медицины
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Український Науково-Дослідний Інститут Промислової Медицини, Украинский Научно-Исследовательский Институт Промышленной Медицины filed Critical Український Науково-Дослідний Інститут Промислової Медицини
Priority to UA99010185A priority Critical patent/UA35854A/en
Publication of UA35854A publication Critical patent/UA35854A/en

Links

Abstract

The invention relates to the medicine. The method for treating the latent silicotuberculosis comprises the intermitting use of Streptomycin and Fluronisid (one day) and Rifampicin (another day). In addition, Levamisol, LIV-52 as hepatoprotector and vitamin E are prescribed.
UA99010185A 1999-01-13 1999-01-13 Method for treating latent silicotuberculosis UA35854A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA99010185A UA35854A (en) 1999-01-13 1999-01-13 Method for treating latent silicotuberculosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA99010185A UA35854A (en) 1999-01-13 1999-01-13 Method for treating latent silicotuberculosis

Publications (1)

Publication Number Publication Date
UA35854A true UA35854A (en) 2001-04-16

Family

ID=74181680

Family Applications (1)

Application Number Title Priority Date Filing Date
UA99010185A UA35854A (en) 1999-01-13 1999-01-13 Method for treating latent silicotuberculosis

Country Status (1)

Country Link
UA (1) UA35854A (en)

Similar Documents

Publication Publication Date Title
MXPA01007451A (en) Substituted porphyrins.
MY169308A (en) Treatment of tnf? related disorders
DK0703786T3 (en) Use of nona- and decapeptides for the manufacture of a medicament for the treatment of AIDS
ATE238307T1 (en) SUBSTITUTED PORPHYRINS
ATE413386T1 (en) PPAR-GAMMA MODULATORS
DK1373215T3 (en) Gelanamycin derivatives suitable for the treatment of cancer
MXPA03006093A (en) N(phenylsulphonyl)glycine derivatives and their therapeutic use.
IL138476A0 (en) Method for treating pharmaceutical compositions by special use of anti-oxidant
PT1143967E (en) USE OF ANTICONVULSIVE DERIVATIVES FOR THE TREATMENT OF SAWS IN SALVAS
GB0109146D0 (en) Treatment of type 2 diabetes
HK1051499A1 (en) Method for treating ocular pain
IL171974A0 (en) Tetrahydrocarbazole derivatives and their pharmaceutical use
HK1040983A1 (en) Quinones for treatment of diseases.
WO2003075953A3 (en) Immunomodulatory polymeric antigens for treating inflammatory pathogies
HK1047707A1 (en) Use of (+)-tramadol, o-demethyltramadol or (+)-o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol or (+)-o-desmethyl-n-mono-desmethyl-tramadol for treating urinary incontinence
HK1029944A1 (en) Treatment of follicular lymphomas using inhibitors of the lymphotoxin (lt) pathway
DK1237562T3 (en) Process for the preparation of micania extracts containing micanolide and dihydromycanolide and use in the treatment of proliferative diseases
DK1189627T3 (en) Compositions containing soluble forms of HLA-G for the treatment of inflammatory pathological conditions in the skin
PL357179A1 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
UA35854A (en) Method for treating latent silicotuberculosis
IL139303A0 (en) Treatment of arthritis and other similar conditions
NZ514691A (en) Method to type prion proteins
BR0008791A (en) Anticonvulsant derivatives, useful in treating essential tremor
UA32288A (en) Method for treating degenerative and inflammatory processes
UA32303A (en) Method for treating papillomatosis